Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer's Disease via Fusion of Clinical, Imaging and Omic Features

被引:14
作者
Singanamalli, Asha [1 ]
Wang, Haibo [1 ]
Madabhushi, Anant [1 ]
机构
[1] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
基金
美国国家卫生研究院; 加拿大健康研究院;
关键词
MILD COGNITIVE IMPAIRMENT; NATIONAL INSTITUTE; CSF BIOMARKERS; CLASSIFICATION; FRAMEWORK; ASSOCIATION; PREDICTION; REPRESENTATION; INTEGRATION; DEMENTIA;
D O I
10.1038/s41598-017-03925-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The introduction of mild cognitive impairment (MCI) as a diagnostic category adds to the challenges of diagnosing Alzheimer's Disease (AD). No single marker has been proven to accurately categorize patients into their respective diagnostic groups. Thus, previous studies have attempted to develop fused predictors of AD and MCI. These studies have two main limitations. Most do not simultaneously consider all diagnostic categories and provide suboptimal fused representations using the same set of modalities for prediction of all classes. In this work, we present a combined framework, cascaded multiview canonical correlation (CaMCCo), for fusion and cascaded classification that incorporates all diagnostic categories and optimizes classification by selectively combining a subset of modalities at each level of the cascade. CaMCCo is evaluated on a data cohort comprising 149 patients for whom neurophysiological, neuroimaging, proteomic and genomic data were available. Results suggest that fusion of select modalities for each classification task outperforms (mean AUC = 0.92) fusion of all modalities (mean AUC = 0.54) and individual modalities (mean AUC = 0.90, 0.53, 0.71, 0.73, 0.62, 0.68). In addition, CaMCCo outperforms all other multi-class classification methods for MCI prediction (PPV: 0.80 vs. 0.67, 0.63).
引用
收藏
页数:14
相关论文
共 43 条
  • [2] Binukumar B., 2013, CANDIDATE BIOMARKERS
  • [3] Brodersen Kay H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764
  • [4] Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset
    Brookmeyer, R
    Gray, S
    Kawas, C
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1998, 88 (09) : 1337 - 1342
  • [5] Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria
    Carrillo, Maria C.
    Dean, Robert A.
    Nicolas, Francois
    Miller, David S.
    Berman, Robert
    Khachaturian, Zaven
    Bain, Lisa J.
    Schindler, Rachel
    Knopman, David
    [J]. ALZHEIMERS & DEMENTIA, 2013, 9 (05) : 594 - 601
  • [6] Positron Emission Tomography Diagnosis of Alzheimer's Disease
    Coleman, R. Edward
    [J]. PET CLINICS, 2007, 2 (01) : 25 - 34
  • [7] Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers
    Da, Xiao
    Toledo, Jon B.
    Zee, Jarcy
    Wolk, David A.
    Xie, Sharon X.
    Ou, Yangming
    Shacklett, Amanda
    Parmpi, Paraskevi
    Shaw, Leslie
    Trojanowski, John Q.
    Davatzikos, Christos
    [J]. NEUROIMAGE-CLINICAL, 2014, 4 : 164 - 173
  • [8] Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification
    Davatzikos, Christos
    Bhatt, Priyanka
    Shaw, Leslie M.
    Batmanghelich, Kayhan N.
    Trojanowski, John Q.
    [J]. NEUROBIOLOGY OF AGING, 2011, 32 (12) : 2322.e19 - 2322.e27
  • [9] MEMORY DISORDERS IN PROBABLE ALZHEIMERS-DISEASE - THE ROLE OF HIPPOCAMPAL ATROPHY AS SHOWN WITH MRI
    DEWEER, B
    LEHERICY, S
    PILLON, B
    BAULAC, M
    CHIRAS, J
    MARSAULT, C
    AGID, Y
    DUBOIS, B
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 58 (05) : 590 - 597
  • [10] An introduction to ROC analysis
    Fawcett, Tom
    [J]. PATTERN RECOGNITION LETTERS, 2006, 27 (08) : 861 - 874